Your browser doesn't support javascript.
loading
Dying cells expose a nuclear antigen cross-reacting with anti-PD-1 monoclonal antibodies.
Metzger, Philipp; Kirchleitner, Sabrina V; Koenig, Lars M; Hörth, Christine; Kobold, Sebastian; Endres, Stefan; Schnurr, Max; Duewell, Peter.
Afiliação
  • Metzger P; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Kirchleitner SV; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Koenig LM; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Hörth C; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Kobold S; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Endres S; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Schnurr M; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany. max.schnurr@med.lmu.de.
  • Duewell P; Center of Integrated Protein Science Munich (CIPSM) and Division of Clinical Pharmacology, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany. peter.duewell@med.uni-muenchen.de.
Sci Rep ; 8(1): 8810, 2018 06 11.
Article em En | MEDLINE | ID: mdl-29892077

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reações Cruzadas / Antígenos Nucleares / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Reações Cruzadas / Antígenos Nucleares / Receptor de Morte Celular Programada 1 / Anticorpos Monoclonais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Sci Rep Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha